Sclerosis – Health

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »

Multiple Sclerosis And Muscle Relaxants

Multiple sclerosis is a health condition that impacts the functioning of the central nervous system. This system consists of numerous nerves that perform the function of informational system in the body, linking all the parts and organs with the brain. Multiple sclerosis affects the myelin sheath – the substance surrounding and protecting the nerves –… Read More »